• +353-1-415-1241(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Mesenchymal Stem Cells - Advances & Applications 2013 - Product Image

Mesenchymal Stem Cells - Advances & Applications 2013

  • Published: June 2013
  • Region: Global
  • 125 Pages
  • BioInformant

FEATURED COMPANIES

  • Abcam
  • Cell Applications
  • Genlantis
  • LGC Standards/ATCC
  • Millipore
  • PromoCell
  • MORE

Understand and profit from the mesenchymal stem cell (MSC) product market – the fastest growing area of stem cell research.

Mesenchymal stem cells (MSCs) are multipotent stem cells that can differentiate into a variety of cell types, including osteoblasts, chondrocytes, myocytes, adipocytes, beta-pancreatic islets cells, and potentially, neuronal cells. MSCs are of intense therapeutic interest because they represent a population of cells with the potential to treat a wide range of acute and degenerative diseases.

MSCs are advantageous over other stem cells types for a variety of reasons: they avoid the ethical issues that surround embryonic stem cell research, and repeated studies have found MSCs to be immuno-privileged, which make them an advantageous cell type for allogenic transplantation. MSCs reduce both the risks of rejection and complications of transplantation. Recently, there have been advances in the use of autologous mesenchymal stem cells to regenerate human tissues, including cartilage, meniscus, tendons, bone fractures, and more.

Trend analysis of grant activity, scientific publication rates, and patent applications trends reveal that global READ MORE >

I. Abstract

II. Overview

A. Definition
B. Alternative Nomenclature
C. Identification
1. Characteristics
2. Functional Attributes
D. Benefits Relative to Other Stem Cell Types

III. Sources

A. Fetal
B. Adult

IV. Cell Types Derived from MSCs

V. Applications

A. Basic Research Applications
1. Directed Differentiation of Autologous MSCs to Intra-Mesenchymal Lineages
2. Directed Differentiation of Autologous MSCs to Extra-Mesenchymal Lineages
B. Supporting Hematopoietic Cells
C. Gene Transfer Applications
D. Cell Transplantation for Site-Specific Repair
1. Overview
2. Major Applications
a. Osteogenic-Focused Research Labs
b. Myogenic and Myocardial Repair
c. Neural Repair
c. Pancreatic Repair
E. Topical Therapy and Use of MSCs in Wound Healing
F. Use of MSC in 3-D Scaffolds for Tissue Engineering Applications
G. Drug Delivery Applications: Engineered MSCs as Carriers of Anti-Cancer Drugs
H. Drug Screening
I. MSC-mediated Inhibition of Immune Effector Cells

VI. Application Priorities

A. Overall
B. By Segment
1. Academic
2. Biotechnology
3. Pharmaceutical

VII. Companies Offering Human MSC Research Products

A. Abcam
B. BD Biosciences
C. Celprogen
D. Cyagen Biosciences (China only)
E. Invitrogen
F. LGC Standards/ATCC
G. Lonza
H. Millipore
I. Miltenyi Biotec
J. PAA - The Cell Culture Company
K. PromoCell
L. SA Biosciences
M. ScienCell Research Laboratories
N. STEMCELLTechnologies
O. Thermo Scientific
P. R&D Systems

VIII. Companies Offering Rodent MSC Research Products

(Note: Eight companies currently offer rat MSC products: Cell Applications, Celprogen, Cyagen Biosciences, Genlantis, Millipore, Miltenyi Biotec, ScienCell Research Laboratories, and Trevigen.)

However, five were profiled in the previous section, leaving three to profile below as limited providers of rat MSC products.)

A. Cell Applications
B. Genlantis
C. Trevigen

IX. Analysis of MSC Research Activity

A. By Tissue Source of Origin
B. By Clinical Application
C. By Species Source
D. By Geographical Region

X. Market Trend Analysis

A. Scientific Publication Rate Analysis
1. Historical 10-Year Analysis
2. Future Five-Year Projection
B. Grant Trend Rate Analysis
1. Historical 10-Year Analysis
2. Future Five-Year Projection
C. Patent Analysis

XI. Mesenchymal Stem Cells as Tools for Drug Discovery

A. Companies Developing Toxicology Screening Platforms for Stem Cells
B. Potential Drug Screening Advantages of Mouse MSCs
1. Acquisition, Handling, and Differentiation Advantages
2. Genetic Manipulation of MSCs
3. Potential for Genetically Engineered MSC Reporter Lines

XII. Serum Free Supplements for Use in MSC Research

A. Invitrogen, Inc.
B. Celprogen
C. Millipore, Inc.
D. Stem Cell Technologies
E. US Patent 7109032: Serum-free medium for mesenchymal stem cells (Genoa, IT)

XIII. End-User Preferences (Scientist Panel)

A. Source Preference
B. Species Preference
C. MSC Product Preferences
D. Most Commonly Used MSC Antibodies
E. Common Terms Used for Online Product Search

XIV. Research Product Opportunities and Suggestions

A. Rat MSCs Derived from Synovium
B. Novel MSC Differentiation Kits
C. Mesenchymal Stem Cell Expansion Media
D. Antibodies to Mesenchymal Stem Cell Markers
E. Mesenchymal Growth Factors
F. Monoclonal Antibodies and Kits for Phenotyping MSCs
G. Chips for MicroArray Analysis of Gene Expression in MSCs

XV. Potential Labs/Customers

A. General MSC Research Labs
B. Osteogenic-Focused Research Labs
C. Myogenic- and Myocardial-Focused Research Labs
D. Adipogenic-Focused Research Labs
E. Neuronal-Focused Research Labs
F. Immunology-Focused Research Labs
G. National Institutes of Health (NIH) Labs
H. Commercial Labs

XVI. Conclusions

Understand and profit from the mesenchymal stem cell (MSC) product market – the fastest growing area of stem cell research.

Put simply, this report will help you understand and profit from the mesenchymal stem cell (MSC) market – the fastest growing area of stem cell research.

Updated to reflect the most current trends and including five year market projections, this report focuses on the advances in MSC research. In 125 pages you'll explore research priorities by market segment, highlight individual labs and end-users of MSC products, understand the competitive environment for such products and discover market-leading trend analysis.

If you're looking to supply stem cell products to this rapidly growing and well-funded market, then this is the report for you. And buy today to get our 60-day money-back guarantee.

Claiming Fast-Growth Opportunities for Yourself

Analysis of global grant activity, scientific publication rates, and patent applications reveal that research activity involving mesenchymal stem cells increased 58% year-over-year from 2008 to 2009, and 112% from 2009 to 2010. Of most interest is that this rate of growth accelerated in 2011, making mesenchymal stem cells the fastest growing area of stem cell research.

Mesenchymal stem cells (MSCs) are multipotent stem cells that can differentiate into a variety of cell types, including osteoblasts, chondrocytes, myocytes, adipocytes, beta-pancreatic islets cells, and potentially, neuronal cells. MSCs are of intense therapeutic interest because they represent a population of cells with the potential to treat a wide range of acute and degenerative diseases.

Revealing Unique Strategic Opportunities & Unknown Competitive Advantages

MSCs are advantageous over other stem cells types for several reasons. First, they avoid the ethical issues that surround embryonic stem cell research. Second, repeated studies have found that human MSCs are immuno-privileged, and therefore, represent an advantageous cell type for allogenic transplantation, reducing the risks of rejection and complications of transplantation. Recently, there have also been significant advances in the use of autologous MSCs to regenerate human tissues, including cartilage and meniscus, tendons, and bone fractures.

This market research report focuses on recent advances in MSC research applications, explores research priorities by market segment, highlights individual labs and end-users of MSC research products, explores the competitive environment for MSC research products, and provides 5-year growth and trend analysis. The report advantageously positions companies that wish to offer competitive stem cells products to this rapidly growing, well-funded research community.

Expanded and Updated Market Intelligence

This is an expanded and updated market intelligence report that includes:

- Updated Charts, Timelines, Metrics and Financials

- 5-Year Projection Data through 2016

- Expanded Competitive Environment Analysis

- Detailed Characterization of the Market, Emphasizing Statistical Trends

- Exploration of Recent Product Evolution and Projected Directions for Development

- Overview of Therapeutic Progress and Insight into Future Applications

- Detailed Evaluation of Profit Opportunities

- New Section on End-User Needs & Technical Preferences (Scientist Survey!)

Can you trust our stem cell market data?

Yes, you can. But we would say that, right?

However, unlike all other stem cell market data companies, at BioInformant we can give you the evidence to back this up. We're the only market intelligence company that has specifically tracked the stem cell product supply market since there was a market.

We monitor all the critical trends in the stem cell industry ensuring all the information you receive is current and strictly relevant to your needs.

It means we understand the current and future product trends more intimately than any other company. When we say we're a global leader in stem cell industry data, you can take that as fact.

And as you can see from our client list to the right of this page, we provide our stem cell data to nearly all of the leading research supply companies in the industry.

- Abcam
- BD Biosciences
- Cell Applications
- Celprogen
- Cyagen Biosciences (China only)
- Genlantis
- Invitrogen
- LGC Standards/ATCC
- Lonza
- Millipore
- Miltenyi Biotec
- PAA - The Cell Culture Company
- PromoCell
- R&D Systems
- SA Biosciences
- ScienCell Research Laboratories
- STEMCELL Technologies Inc
- Thermo Scientific
- Trevigen, Inc.

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos